A detailed history of Black Rock Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,609,338 shares of RGNX stock, worth $95.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,609,338
Previous 7,599,242 13.29%
Holding current value
$95.9 Million
Previous $160 Million 37.09%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.51 - $21.53 $11.6 Million - $21.7 Million
1,010,096 Added 13.29%
8,609,338 $101 Million
Q1 2024

May 10, 2024

SELL
$12.17 - $24.61 $7.4 Million - $15 Million
-608,306 Reduced 7.41%
7,599,242 $160 Million
Q4 2023

Feb 13, 2024

BUY
$12.89 - $20.82 $2.33 Million - $3.77 Million
181,058 Added 2.26%
8,207,548 $147 Million
Q3 2023

Nov 13, 2023

SELL
$16.46 - $19.99 $3.99 Million - $4.85 Million
-242,482 Reduced 2.93%
8,026,490 $132 Million
Q2 2023

Aug 11, 2023

BUY
$17.23 - $21.71 $3.93 Million - $4.95 Million
228,182 Added 2.84%
8,268,972 $165 Million
Q1 2023

May 12, 2023

BUY
$18.08 - $24.55 $24.5 Million - $33.3 Million
1,354,440 Added 20.26%
8,040,790 $152 Million
Q4 2022

Feb 13, 2023

BUY
$20.4 - $24.73 $2.76 Million - $3.34 Million
135,074 Added 2.06%
6,686,350 $152 Million
Q3 2022

Nov 14, 2022

SELL
$22.29 - $35.04 $1.71 Million - $2.69 Million
-76,847 Reduced 1.16%
6,551,276 $173 Million
Q2 2022

Aug 12, 2022

BUY
$19.35 - $35.04 $760,609 - $1.38 Million
39,308 Added 0.6%
6,628,123 $164 Million
Q1 2022

May 12, 2022

BUY
$24.62 - $34.31 $427,821 - $596,204
17,377 Added 0.26%
6,588,815 $219 Million
Q4 2021

Feb 10, 2022

BUY
$30.19 - $40.28 $6.33 Million - $8.44 Million
209,635 Added 3.3%
6,571,438 $215 Million
Q3 2021

Nov 09, 2021

BUY
$29.09 - $45.68 $4.67 Million - $7.34 Million
160,702 Added 2.59%
6,361,803 $267 Million
Q2 2021

Aug 11, 2021

BUY
$32.46 - $40.48 $201 Million - $251 Million
6,201,101 New
6,201,101 $241 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $482M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.